Sat09222018

Robins Global News & Noticias



  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering


WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $75.0 million before underwriting discounts and commissions and estimated offering expenses.  In addition, Verrica has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the common stock is being offered by Verrica. The shares are scheduled to begin trading on the Nasdaq Global Market on June 15, 2018 under the ticker symbol “VRCA.” The offering is expected to close on June 19, 2018, subject to customary closing conditions.
BofA Merrill Lynch, Jefferies and Cowen are serving as joint book-running managers for the offering.A registration statement relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission on June 14, 2018.  This offering is being made only by means of a prospectus.  A copy of the final prospectus can be obtained, when available, from: BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; Jefferies, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by phone at 1-877-821-7388 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; or Cowen, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by telephone at (631) 274-2806.This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Verrica Pharmaceuticals Inc.Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase ...


Posted: 2018-06-14 21:52:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering | Globe NewsWire News Distribution Service - Newscast

Farfetch Limited Announces Pricing of Initial Public Offering

Thu, 20 Sep 2018 16:46:00 GMT

LONDON--(BUSINESS WIRE)--Farfetch Limited (“Farfetch”), a leading technology platform for the global luxury fashion industry, announced today the pricing of its initial public offering of 44,243,749 C...

Y-mAbs Therapeutics Announces Pricing of Initial Public Offering

Thu, 20 Sep 2018 16:25:00 GMT

NEW YORK, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development ...

Eventbrite Announces Pricing of Initial Public Offering

Wed, 19 Sep 2018 17:45:00 GMT

SAN FRANCISCO--(BUSINESS WIRE)--Eventbrite, a global ticketing and event technology platform, today announced the pricing of its initial public offering of 10,000,000 shares of its Class A common stoc...

Elanco Announces Pricing of Initial Public Offering

Wed, 19 Sep 2018 14:34:00 GMT

Elanco Animal Health Incorporated, a subsidiary of Eli Lilly and Company (LLY), announced today the pricing of its initial public offering (IPO) of 62.9 million shares of its common stock at a ...

Bank7 Corp. Prices Upsized Initial Public Offering of Common Stock

Wed, 19 Sep 2018 10:26:00 GMT

OKLAHOMA CITY, Sept. 19, 2018 (GLOBE NEWSWIRE) — Bank7 Corp., the bank holding company for Bank7, today announced the pricing of its upsized initial public offering of 3,400,000 shares of common ...

Related Bing Web Search

Eventbrite Announces Pricing of Initial Public Offering ...

(Wed, 19 Sep 2018 20:40:00 GMT)

Eventbrite, a global ticketing and event technology platform, today announced the pricing of its initial public offering of 10,000,000 shares of its C

Replimune Announces Pricing of Initial Public Offering

(Tue, 18 Sep 2018 06:51:00 GMT)

WOBURN, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Replimune Group, Inc., a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the pricing of its initial public offering of 6,700,000 shares of common stock at a public offering price of $15.00 per share for gross proceeds of $100.5 million, before underwriting discounts and ...

Domo, Inc. Announces Pricing of Initial Public Offering ...

(Thu, 28 Jun 2018 23:44:00 GMT)

SILICON SLOPES, Utah, June 28, 2018 (GLOBE NEWSWIRE) -- Domo, Inc. (Nasdaq:DOMO) today announced the pricing of its initial public offering of 9,200,000 shares of Class B common stock at a price ...

Avalara Announces Pricing of Initial Public Offering

(Fri, 15 Jun 2018 14:41:00 GMT)

Avalara, Inc. (AVLR) today announced the pricing of its initial public offering of 7,500,000 shares of its common stock at a public offering price of $24.00 per share. The shares are expected to ...

EverQuote Announces Pricing of Initial Public Offering

(Thu, 13 Sep 2018 20:04:00 GMT)

EverQuote, Inc. ("EverQuote"), a leading online insurance marketplace in the U.S., connecting consumers with insurance providers, today announced the pricing of its initial public offering of 4,687,500 shares of its Class A common stock at a public offering price of $18 per share, before underwriting discounts and commissions. The shares are scheduled to begin trading on the Nasdaq Global ...

Spartan Energy Acquisition Corp. Announces Pricing of ...

(Thu, 09 Aug 2018 16:49:00 GMT)

Spartan Energy Acquisition Corp. Announces Pricing of $400,000,000 Initial Public Offering. August 09, 2018 04:56 PM Eastern Daylight Time ... today announced the pricing of its initial public ...

DocuSign Announces Pricing of Initial Public Offering

(Sun, 16 Sep 2018 14:17:00 GMT)

SAN FRANCISCO, April 26, 2018 /PRNewswire/ -- DocuSign, Inc. today announced the pricing of its initial public offering of 21,700,000 shares of common

EVO Announces Pricing of Initial Public Offering Nasdaq:EVOP

(Wed, 23 May 2018 02:23:00 GMT)

ATLANTA, May 22, 2018 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (“EVO”) announced today the pricing of its initial public offering of 14,000,000 shares of its Class A common stock at a price to ...

Amalgamated Bank Announces Pricing of Initial Public ...

(Wed, 08 Aug 2018 06:21:00 GMT)

NEW YORK, Aug. 08, 2018-- Amalgamated Bank today announced the pricing of its initial public offering of 6,718,729 million shares of Class A common.

Crinetics Pharmaceuticals Announces Pricing of Initial ...

(Mon, 16 Jul 2018 23:59:00 GMT)

In addition, Crinetics has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the initial public offering price, less underwriting discounts ...

Related News Story Videos From Youtube

ARC287bc, Corp. Announces Pricing of Initial Public Offering


Related Videos On: ARC287bc, Corp. Announces Pricing of Initial Public Offering


Cushman & Wakefield Announces Pricing of Initial Public Offering(Press Video: AETOSWire)


Related Videos On: Cushman & Wakefield Announces Pricing of Initial Public Offering(Press Video: AETOSWire)


Stocks to buy: NIO Inc. (NYSE: NIO)


Related Videos On: Stocks to buy: NIO Inc. (NYSE: NIO)


Quanterix Corporation Announces Pricing of Initial Public Offering


Related Videos On: Quanterix Corporation Announces Pricing of Initial Public Offering


What Is An Underwritten Public Offering?


Related Videos On: What Is An Underwritten Public Offering?






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2018 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.